Create a free Feed & Grain account to continue reading

Millers, oilseed processors seek more time on FDA GRAS rule

The Food and Beverage Issue Alliance wants 90 more days to weigh a proposal that would require GRAS notices for food and feed ingredients already on the market.

Major food industry groups including millers and oilseed processors have requested a 90-day extension from the FDA to comment on a proposed rule that would make GRAS (generally recognized as safe) notices mandatory for food and animal feed ingredients, citing the need to consult with diverse stakeholders about this significant regulatory shift.

  • The North American Millers' Association and National Oilseed Processors Association led a request for a 90-day comment period extension on the FDA's proposed GRAS rule.
  • The current comment deadline is December 9, 2024, but industry groups say they need more time to assess the proposal's impact across their member companies.
  • The proposed rule would require companies to notify the FDA of GRAS conclusions before marketing substances, even those already in the food supply, representing a major shift from current practice.
  • The rule applies to both food and animal feed, with compliance required 18 months after the final rule takes effect.
  • The FDA estimates the rule will cost $89.6 million over 10 years and require approximately 155 one-time submissions from animal food firms.

The North American Millers' Association, the National Oilseed Processors Association and 19 other food and beverage trade groups have asked the Food and Drug Administration (FDA) for 90 more days to comment on its plan to make generally recognized as safe, or GRAS, notices mandatory.

The groups, all members of the Food and Beverage Issue Alliance, made the request in a Nov. 5 letter to FDA's Dockets Management Staff, with a copy to Don Prater, acting deputy commissioner for food. Signers include the American Bakers Association, FMI — The Food Industry Association and the American Spice Trade Association. The comment period on the proposed rule, published Aug. 11, closes Dec. 9.

The alliance, which represents 48 U.S. food and beverage trade associations, said its member companies differ widely in scale, product categories and technical capability, and that it must reach a broad set of stakeholders to reflect their operations.

"The proposed rule represents a significant shift in the long-standing GRAS framework," the groups said in the letter.

The mechanics explain the pushback. Under the proposal, anyone introducing a substance into interstate commerce under the GRAS provision would have to notify FDA of the basis for its GRAS conclusion unless an exception applies. That covers substances already in the food supply, not only new ones. Companies could still reach their own GRAS conclusions and market a substance before FDA responds, but they would generally have to file those conclusions with the agency.

The rule reaches feed as well as food. Parallel changes to the animal food regulations would route notices through FDA's Center for Veterinary Medicine. Animal food exceptions include substances with an existing FDA "no questions" letter, uses reviewed through the center's Animal Food Ingredient Consultation process and ingredients listed in, and used according to, Chapter 6 of the 2024 edition of the Association of American Feed Control Officials Official Publication, unless FDA has publicly raised a concern about the use.

For substances already on the market, firms would get one year after the final rule takes effect to file a streamlined submission that does not require underlying safety data. A final rule would take effect 60 days after publication, with compliance due 18 months after that. FDA estimates 62 animal food firms would make about 155 of those one-time submissions. The agency put the rule's 10-year cost at a central estimate of $89.6 million in present value at a 3% discount rate.

The American Feed Industry Association (AFIA) said in an Aug. 10 statement that it is reviewing the proposal's effect on animal food ingredient approvals and will file comments. Constance Cullman, AFIA president and CEO, tied the group's concerns to agency capacity.

"As the FDA considers potential changes, it is critical that the agency has the resources, capacity and tools needed to administer ingredient reviews in a timely manner," Cullman said.

FDA had not published an extension in the Federal Register as of Nov. 19. Unless the agency acts, comments under docket FDA-2025-N-3262 are due by 11:59 p.m. Eastern time Dec. 9.

Page 1 of 81
Next Page